首页> 外文期刊>Synthesis and reactivity in inorganic, metal-organic, and nano-metal chemistry >Synthesis and Evaluation of Neutral Gd(III), Mn(II) Complexes From DTPA-Bisamide Derivative as Potential MRI Contrast Agents
【24h】

Synthesis and Evaluation of Neutral Gd(III), Mn(II) Complexes From DTPA-Bisamide Derivative as Potential MRI Contrast Agents

机译:DTPA-双酰胺衍生物作为潜在的MRI造影剂的中性Gd(III),Mn(II)配合物的合成与评价

获取原文
获取原文并翻译 | 示例
           

摘要

A strong chelating ligand was synthesized through the modification of DTPA by bioactive 5-fluorouracil derivatives and characterized by means of mass spectra, Fourier transform infrared spectra, elemental analysis, and nuclear magnetic resonance spectroscopy. Its complexes of Gd(III) and Mn(II) were designed as potential MRI contrast agents. Thermodynamic stability constant of the complexes indicated that they were stable enough to prevent the metal ions from releasing. Relaxivity studies showed that the two complexes provided higher T-1-weighted relaxivity than that of commercial contrast agent Gd-DTPA and the Mn(II) complex owned much higher T-2-weighted relaxation property. Both the Gd(III) and Mn(II) complexes had the advantage of becoming promising T-1-weighted MRI contrast agents.
机译:通过生物活性的5-氟尿嘧啶衍生物对DTPA进行修饰,合成了强螯合配体,并通过质谱,傅立叶变换红外光谱,元素分析和核磁共振波谱进行了表征。 Gd(III)和Mn(II)的配合物被设计为潜在的MRI造影剂。配合物的热力学稳定性常数表明它们足够稳定以防止金属离子释放。弛豫性研究表明,这两种配合物比商业造影剂Gd-DTPA提供更高的T-1加权弛豫性,而Mn(II)络合物具有更高的T-2加权弛豫性能。 Gd(III)和Mn(II)配合物均具有成为有前途的T-1加权MRI造影剂的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号